CD160 Antibody (Center) Blocking Peptide

CD160 Antibody (Center) Blocking Peptide

€363.00
In stock
SKU
AC-BP9869c
Catalog Number: AC-BP9869c
Size: 500 µg
Datasheet
Request Information
Background:
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is expressed by CD56dimCD16+ cells whereas among circulating T cells its expression is mainly restricted to TCRgd bearing cells and to TCRab+CD8brightCD95+CD56+CD28-CD27-cells. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules.

Other Names:
CD160 antigen, Natural killer cell receptor BY55, CD160, CD160, BY55

Gene Name: CD160 {ECO:0000303|PubMed:16809620, ECO:0000312|HGNC:HGNC:17013}

Gene ID: 11126
Primary Accession: O95971
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:CD160 Antibody (Center) Blocking Peptide